wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36462972-69857199-6504-44CF-A4EA-86E8D143C77A
Q36462972-69857199-6504-44CF-A4EA-86E8D143C77A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36462972-69857199-6504-44CF-A4EA-86E8D143C77A
A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer.
P50
Q36462972-69857199-6504-44CF-A4EA-86E8D143C77A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36462972-69857199-6504-44CF-A4EA-86E8D143C77A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
867a5062e32859ab2559f893b9253c935480246b
P1545
6
http://www.w3.org/2001/XMLSchema#string
P50
Sebastien Taurin